Elorac, Inc. Announces Clinical Results of Carbamide Peroxide Studies for the Treatment of Acne
11/19/2010 10:41:53 AM
CHICAGO--(BUSINESS WIRE)--Elorac, Inc., a rapidly growing specialty pharmaceutical company focused on the treatment of dermatological disorders, announced results of two Phase III studies of its patented Carbamide Peroxide (CPO) solution for the treatment of inflammatory acne vulgaris and rosacea at the Lazard Capital Markets 7th Annual Healthcare Conference in New York.
comments powered by